These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26661248)

  • 1. Pharmacology in cerebrovascular disease research: Pharmacokinetics-pharmacodynamics to the rescue.
    Feuerstein GZ
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):639-44. PubMed ID: 26661248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery.
    Zhang R; Wong K
    Expert Opin Drug Discov; 2017 Jan; 12(1):17-37. PubMed ID: 27784173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development.
    Dingemanse J; Krause A
    Eur J Pharm Sci; 2017 Nov; 109S():S53-S58. PubMed ID: 28535992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development.
    Gupta N; Bottino D; Simonsson USH; Musante CJ; Bueters T; Rieger TR; Macha S; Chenel M; Fancourt C; Kanodia J; Nayak S
    Clin Pharmacol Ther; 2020 Jun; 107(6):1285-1289. PubMed ID: 31709519
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.
    Visser SAG; Bueters TJH
    Eur J Pharm Sci; 2017 Nov; 109S():S72-S77. PubMed ID: 28811131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish models of cerebrovascular disease.
    Walcott BP; Peterson RT
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):571-7. PubMed ID: 24517974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational PK/PD modeling to increase probability of success in drug discovery and early development.
    Lavé T; Caruso A; Parrott N; Walz A
    Drug Discov Today Technol; 2016; 21-22():27-34. PubMed ID: 27978984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonprofit foundations spur translational research.
    Zaratin P; Battaglia MA; Abbracchio MP
    Trends Pharmacol Sci; 2014 Nov; 35(11):552-5. PubMed ID: 25441773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs.
    Zhang R; Monsma F
    Expert Opin Drug Discov; 2010 Nov; 5(11):1023-9. PubMed ID: 22827742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational medicine for stroke drug discovery: the pharmaceutical industry perspective.
    Feuerstein GZ; Chavez J
    Stroke; 2009 Mar; 40(3 Suppl):S121-5. PubMed ID: 19064772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Science - An Underappreciated Component of Translational Research.
    Rouse R; Zineh I; Strauss DG
    Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-target interaction kinetics: underutilized in drug optimization?
    Copeland RA
    Future Med Chem; 2016 Dec; 8(18):2173-2175. PubMed ID: 27845591
    [No Abstract]   [Full Text] [Related]  

  • 17. Forty years of translational cancer research.
    Hait WN
    Cancer Discov; 2011 Oct; 1(5):383-90. PubMed ID: 22586630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
    Brunner D; Balcı F; Ludvig EA
    Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating new approaches for clinical development: translational research and relative effectiveness.
    Lehner JP; Epstein RS; Salimi T
    J Comp Eff Res; 2012 Jan; 1(1 Suppl):15-21. PubMed ID: 24237318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives.
    Bueters T; Ploeger BA; Visser SA
    Drug Discov Today; 2013 Sep; 18(17-18):853-62. PubMed ID: 23665277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.